Dignify Therapeutics

Dignify Therapeutics’ Chief Scientific Officer invited to participate r at CURE-UAB

Dignify Therapeutics’ Chief Scientific Officer, Karl B. Thor, PhD, has been invited to participate as a Faculty member at the 2nd International Congress on Underactive Bladder – CURE-UAB in Denver, CO, Dec. 3-4, 2015.  His presentation is entitled “Pharmaceutical Targets for Drug-induced Voiding”.  This NIH-sponsored congress brings together academic, pharmaceutical, and medical device experts to provide a multidisciplinary forum for addressing the unmet medical need for therapy to treat urinary voiding dysfunction.  The Congress is being organized by Dr. Michael CHancellor, Director of NeuroUrology, Beaumont Hospital, MI.

For more information, please visit: Underactivebladder.org

Underactive Bladder